Indium In-111

DB11916InvestigationalSmall molecule

Indium In-111 is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas).

Chemical structure of Indium In-111
Formula / weight
In · 110.9051 g/mol (avg)
Also known as
Indium (111 In)

Resolves to

Compound
UNIIE9NGC49E0TCAS15750-15-9PubChem5462099
Clinical / RWD
RxNorm90540
Structure
InChIKeyAPFVFJFRJDLVQX-AHCXROLUSA-NSMILES[111In]

What you can answer from here — as of April 02, 2025

1Marketed productAcross 1 country and 1 labeller
Sign in

Which companies are running trials of Indium In-111, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In